300 related articles for article (PubMed ID: 28285208)
1. Predictors of tobacco abstinence in outpatient smokers with schizophrenia or bipolar disorder treated with varenicline and cognitive behavioral smoking cessation therapy.
Schuster RM; Cather C; Pachas GN; Zhang H; Cieslak KM; Hoeppner SS; Schoenfeld D; Evins AE
Addict Behav; 2017 Aug; 71():89-95. PubMed ID: 28285208
[TBL] [Abstract][Full Text] [Related]
2. Maintenance treatment with varenicline for smoking cessation in patients with schizophrenia and bipolar disorder: a randomized clinical trial.
Evins AE; Cather C; Pratt SA; Pachas GN; Hoeppner SS; Goff DC; Achtyes ED; Ayer D; Schoenfeld DA
JAMA; 2014 Jan; 311(2):145-54. PubMed ID: 24399553
[TBL] [Abstract][Full Text] [Related]
3. Anxiety Sensitivity and Distress Tolerance in Smokers: Relations With Tobacco Dependence, Withdrawal, and Quitting Success†.
Schlam TR; Baker TB; Smith SS; Cook JW; Piper ME
Nicotine Tob Res; 2020 Jan; 22(1):58-65. PubMed ID: 31056710
[TBL] [Abstract][Full Text] [Related]
4. Varenicline versus nicotine patch with brief advice for smokers with substance use disorders with or without depression: effects on smoking, substance use and depressive symptoms.
Rohsenow DJ; Tidey JW; Martin RA; Colby SM; Swift RM; Leggio L; Monti PM
Addiction; 2017 Oct; 112(10):1808-1820. PubMed ID: 28498504
[TBL] [Abstract][Full Text] [Related]
5. Maintenance pharmacotherapy normalizes the relapse curve in recently abstinent tobacco smokers with schizophrenia and bipolar disorder.
Evins AE; Hoeppner SS; Schoenfeld DA; Hoeppner BB; Cather C; Pachas GN; Cieslak KM; Maravic MC
Schizophr Res; 2017 May; 183():124-129. PubMed ID: 27956009
[TBL] [Abstract][Full Text] [Related]
6. Varenicline for tobacco-dependence treatment in alcohol-dependent smokers: A randomized controlled trial.
Hurt RT; Ebbert JO; Croghan IT; Schroeder DR; Hurt RD; Hays JT
Drug Alcohol Depend; 2018 Mar; 184():12-17. PubMed ID: 29324248
[TBL] [Abstract][Full Text] [Related]
7. Improved Depressive Symptoms in Adults with Schizophrenia During a Smoking Cessation Attempt with Varenicline and Behavioral Therapy.
Cather C; Hoeppner S; Pachas G; Pratt S; Achtyes E; Cieslak KM; Evins AE
J Dual Diagn; 2017; 13(3):168-178. PubMed ID: 28414583
[TBL] [Abstract][Full Text] [Related]
8. Effects on abstinence of nicotine patch treatment before quitting smoking: parallel, two arm, pragmatic randomised trial.
Preloading Investigators
BMJ; 2018 Jun; 361():k2164. PubMed ID: 29899061
[TBL] [Abstract][Full Text] [Related]
9. The efficacy of varenicline in achieving abstinence among waterpipe tobacco smokers - study protocol for a randomized controlled trial.
Zahid R; Dogar O; Mansoor S; Khan A; Kanaan M; Jawad M; Ahluwalia JS; Siddiqi K
Trials; 2017 Jan; 18(1):14. PubMed ID: 28077163
[TBL] [Abstract][Full Text] [Related]
10. Zonisamide Reduces Withdrawal Symptoms But Does Not Enhance Varenicline-Induced Smoking Cessation.
Dunn KE; Marcus TF; Kim C; Schroeder JR; Vandrey R; Umbricht A
Nicotine Tob Res; 2016 May; 18(5):1171-9. PubMed ID: 26476459
[TBL] [Abstract][Full Text] [Related]
11. Flexible, dual-form nicotine replacement therapy or varenicline in comparison with nicotine patch for smoking cessation: a randomized controlled trial.
Tulloch HE; Pipe AL; Els C; Clyde MJ; Reid RD
BMC Med; 2016 Jun; 14():80. PubMed ID: 27233840
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of varenicline and counselling for smoking cessation in an observational cohort study in China.
Jiang B; He Y; Zuo F; Wu L; Liu QH; Zhang L; Zhou CX; Cheng KK; Chan SS; Lam TH
BMJ Open; 2016 Jan; 6(1):e009381. PubMed ID: 26739730
[TBL] [Abstract][Full Text] [Related]
13. Effective Cessation Strategies for Smokers with Schizophrenia.
Evins AE; Cather C
Int Rev Neurobiol; 2015; 124():133-47. PubMed ID: 26472528
[TBL] [Abstract][Full Text] [Related]
14. Effects of Nicotine Patch vs Varenicline vs Combination Nicotine Replacement Therapy on Smoking Cessation at 26 Weeks: A Randomized Clinical Trial.
Baker TB; Piper ME; Stein JH; Smith SS; Bolt DM; Fraser DL; Fiore MC
JAMA; 2016 Jan; 315(4):371-9. PubMed ID: 26813210
[TBL] [Abstract][Full Text] [Related]
15. Predictors of lapse and relapse to smoking in successful quitters in a varenicline post hoc analysis in Japanese smokers.
Nakamura M; Oshima A; Ohkura M; Arteaga C; Suwa K
Clin Ther; 2014 Jun; 36(6):918-27. PubMed ID: 24811751
[TBL] [Abstract][Full Text] [Related]
16. Neural Signatures of Cognitive Flexibility and Reward Sensitivity Following Nicotinic Receptor Stimulation in Dependent Smokers: A Randomized Trial.
Lesage E; Aronson SE; Sutherland MT; Ross TJ; Salmeron BJ; Stein EA
JAMA Psychiatry; 2017 Jun; 74(6):632-640. PubMed ID: 28403383
[TBL] [Abstract][Full Text] [Related]
17. Varenicline treatment of concurrent alcohol and nicotine dependence in schizophrenia: a randomized, placebo-controlled pilot trial.
Meszaros ZS; Abdul-Malak Y; Dimmock JA; Wang D; Ajagbe TO; Batki SL
J Clin Psychopharmacol; 2013 Apr; 33(2):243-7. PubMed ID: 23422399
[TBL] [Abstract][Full Text] [Related]
18. Varenicline in the routine treatment of tobacco dependence: a pre-post comparison with nicotine replacement therapy and an evaluation in those with mental illness.
Stapleton JA; Watson L; Spirling LI; Smith R; Milbrandt A; Ratcliffe M; Sutherland G
Addiction; 2008 Jan; 103(1):146-54. PubMed ID: 18028247
[TBL] [Abstract][Full Text] [Related]
19. Effects of Varenicline, Depressive Symptoms, and Region of Enrollment on Smoking Cessation in Depressed Smokers.
Doran N; Dubrava S; Anthenelli RM
Nicotine Tob Res; 2019 Jan; 21(2):156-162. PubMed ID: 29471329
[TBL] [Abstract][Full Text] [Related]
20. Varenicline as a smoking cessation aid in schizophrenia: effects on smoking behavior and reward sensitivity.
Dutra SJ; Stoeckel LE; Carlini SV; Pizzagalli DA; Evins AE
Psychopharmacology (Berl); 2012 Jan; 219(1):25-34. PubMed ID: 21695488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
